Works by Lashner, Bret A.

Results: 74
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.

    Published in:
    Infectious Diseases & Therapy, 2024, v. 13, n. 10, p. 2105, doi. 10.1007/s40121-024-01007-z
    By:
    • Kraft, Colleen S.;
    • Sims, Matthew;
    • Silverman, Michael;
    • Louie, Thomas J.;
    • Feuerstadt, Paul;
    • Huang, Edward S.;
    • Khanna, Sahil;
    • Berenson, Charles S.;
    • Wang, Elaine E. L.;
    • Cohen, Stuart H.;
    • Korman, Louis;
    • Lee, Christine;
    • Kelly, Colleen R.;
    • Odio, Alberto;
    • Cook, Paul P.;
    • Lashner, Bret;
    • Ramesh, Mayur;
    • Kumar, Princy;
    • De, Ananya;
    • Memisoglu, Asli
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 2, p. e2255758, doi. 10.1001/jamanetworkopen.2022.55758
    By:
    • Sims, Matthew D.;
    • Khanna, Sahil;
    • Feuerstadt, Paul;
    • Louie, Thomas J.;
    • Kelly, Colleen R.;
    • Huang, Edward S.;
    • Hohmann, Elizabeth L.;
    • Wang, Elaine E. L.;
    • Oneto, Caterina;
    • Cohen, Stuart H.;
    • Berenson, Charles S.;
    • Korman, Louis;
    • Lee, Christine;
    • Lashner, Bret;
    • Kraft, Colleen S.;
    • Ramesh, Mayur;
    • Silverman, Michael;
    • Pardi, Darrell S.;
    • De, Ananya;
    • Memisoglu, Asli
    Publication type:
    Article
    18

    Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 11, p. 1504, doi. 10.1093/cid/ciad448
    By:
    • Berenson, Charles S;
    • Lashner, Bret;
    • Korman, Louis Y;
    • Hohmann, Elizabeth;
    • Deshpande, Abhishek;
    • Louie, Thomas J;
    • Sims, Matthew;
    • Pardi, Darrell;
    • Kraft, Colleen S;
    • Wang, Elaine E L;
    • Cohen, Stuart H;
    • Feuerstadt, Paul;
    • Oneto, Caterina;
    • Misra, Bharat;
    • Pullman, John;
    • De, Ananya;
    • Memisoglu, Asli;
    • Lombardi, David A;
    • Hasson, Brooke R;
    • McGovern, Barbara H
    Publication type:
    Article
    19
    20
    21
    22

    Sarcoidosis Presenting as Granulomatous Colitis.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 10, p. 1949, doi. 10.1111/j.1572-0241.1998.00552.x
    By:
    • Dumot, John A.;
    • Adal, Karim;
    • Petras, Robert E.;
    • Lashner, Bret A.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Editorial.

    Published in:
    1994
    By:
    • Lashner, Bret A.
    Publication type:
    Editorial
    30
    31
    32
    33
    34
    35
    36

    Cigarette Smoking in Crohn's Disease.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 1989, v. 84, n. 1, p. 31
    By:
    • Silverstein, Marc D.;
    • Lashner, Bret A.;
    • Hanauer, Stephen B.;
    • Evans, Alison A.;
    • Kirsner, Joseph B.
    Publication type:
    Article
    37
    38
    39
    40
    41

    Mild neoterminal ileal post‐operative recurrence of Crohn's disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesions.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 9, p. 1139, doi. 10.1111/apt.16804
    By:
    • Bachour, Salam P.;
    • Shah, Ravi S.;
    • Lyu, Ruishen;
    • Rieder, Florian;
    • Qazi, Taha;
    • Lashner, Bret;
    • Achkar, Jean Paul;
    • Philpott, Jessica;
    • Barnes, Edward L.;
    • Axelrad, Jordan;
    • Holubar, Stefan D.;
    • Lightner, Amy L.;
    • Regueiro, Miguel;
    • Cohen, Benjamin L.;
    • Click, Benjamin H.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 2, p. 199, doi. 10.1038/ajg.2010.392
    By:
    • D'Haens, Geert R.;
    • Panaccione, Remo;
    • Higgins, Peter D. R.;
    • Vermeire, Severine;
    • Gassull, Miquel;
    • Chowers, Yehuda;
    • Hanauer, Stephen B.;
    • Herfarth, Hans;
    • Hommes, Daan W.;
    • Kamm, Michael;
    • Löfberg, Robert;
    • Quary, A.;
    • Sands, Bruce;
    • Sood, A.;
    • Watermayer, G.;
    • Lashner, Bret;
    • Lémann, Marc;
    • Plevy, Scott;
    • Reinisch, Walter;
    • Schreiber, Stefan
    Publication type:
    Article
    49

    Corrigendum: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

    Published in:
    2011
    By:
    • D'Haens, Geert R;
    • Panaccione, Remo;
    • Higgins, Peter D R;
    • Vermeire, Severine;
    • Gassull, Miquel;
    • Chowers, Yehuda;
    • Hanauer, Stephen B;
    • Herfarth, Hans;
    • Hommes, Daan W;
    • Kamm, Michael;
    • Löfberg, Robert;
    • Quary, A;
    • Sands, Bruce;
    • Sood, A;
    • Watermayer, G;
    • Lashner, Bret;
    • Lémann, Marc;
    • Plevy, Scott;
    • Reinisch, Walter;
    • Schreiber, Stefan
    Publication type:
    Correction Notice
    50